Parkinson’s disease monitoring technology awarded new patent

2:55 pm by | 0 Comments

Great Lakes NeuroTechnologies has been awarded a new patent for its technology that quantifies the severity of movement disorders in Parkinson’s disease patients.

Great Lakes’ Kinesia movement disorder assessment technology uses a ring-like sensor worn on a patient’s finger to measure motor symptoms and wirelessly transmit data to physicians on the severity of a patient’s tremors.

The newly issued patents cover various aspects of the patient-worn device as well as the technology that processes and transmits movement disorder data, according to a statement from Valley View, Ohio-based Great Lakes.


The idea behind the company’s movement disorder assessment system is that understanding the type and severity of tremors, slowed movements and medication side effects a patient experiences will help doctors better prescribe medications to minimize the patient’s fluctuations throughout the course of a day.

Earlier this year, Great Lakes secured $4.5 million in grant funding through the National Institutes of Health’s Small Business Innovation Research (SBIR) program.

The company is conducting a study of 60 patients with essential tremor, a type of involuntary shaking of the body, as they conduct their daily lives in their homes.

Great Lakes is also planning a study that would assess its technology in helping surgeons and neurologists fine-tune deep brain stimulation (DBS) systems after they’ve been implanted in Parkinson’s patients.

Copyright 2015 MedCity News. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Brandon Glenn

By Brandon Glenn MedCity News

Brandon Glenn is the Ohio bureau chief for MedCity News.
More posts by Author